| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| T-Box Domain Proteins | 58 | 2021 | 468 | 5.220 |
Why?
|
| DNA-Binding Proteins | 118 | 2018 | 9585 | 5.060 |
Why?
|
| Transcription Factors | 126 | 2021 | 12103 | 4.270 |
Why?
|
| Histocompatibility Antigens Class II | 85 | 1999 | 1446 | 3.290 |
Why?
|
| Endoribonucleases | 17 | 2019 | 229 | 3.090 |
Why?
|
| Genes, MHC Class II | 55 | 2009 | 451 | 2.860 |
Why?
|
| Interleukin-4 | 47 | 2015 | 1130 | 2.550 |
Why?
|
| Th2 Cells | 31 | 2021 | 1047 | 2.120 |
Why?
|
| Th1 Cells | 33 | 2010 | 1032 | 2.110 |
Why?
|
| Osteoblasts | 20 | 2018 | 1142 | 1.960 |
Why?
|
| Nuclear Proteins | 39 | 2024 | 5791 | 1.930 |
Why?
|
| Endoplasmic Reticulum | 24 | 2016 | 1132 | 1.910 |
Why?
|
| Cell Differentiation | 71 | 2021 | 11481 | 1.900 |
Why?
|
| Gene Expression Regulation | 74 | 2024 | 11903 | 1.820 |
Why?
|
| NFATC Transcription Factors | 29 | 2013 | 381 | 1.790 |
Why?
|
| Unfolded Protein Response | 13 | 2020 | 233 | 1.710 |
Why?
|
| T-Lymphocytes | 76 | 2018 | 10181 | 1.710 |
Why?
|
| B-Lymphocytes | 58 | 2020 | 4742 | 1.600 |
Why?
|
| Dendritic Cells | 18 | 2020 | 2725 | 1.580 |
Why?
|
| Plasma Cells | 8 | 2020 | 591 | 1.580 |
Why?
|
| Mice | 298 | 2021 | 81208 | 1.550 |
Why?
|
| Animals | 336 | 2021 | 167963 | 1.350 |
Why?
|
| Mice, Knockout | 80 | 2021 | 14372 | 1.350 |
Why?
|
| Interferon-gamma | 32 | 2020 | 3157 | 1.330 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 21 | 2020 | 975 | 1.290 |
Why?
|
| Mice, Inbred BALB C | 73 | 2018 | 6216 | 1.280 |
Why?
|
| MAP Kinase Kinase Kinases | 4 | 2011 | 256 | 1.270 |
Why?
|
| Awards and Prizes | 2 | 2022 | 359 | 1.180 |
Why?
|
| Lymphocyte Activation | 48 | 2020 | 5496 | 1.150 |
Why?
|
| Immunity, Innate | 14 | 2020 | 3047 | 1.150 |
Why?
|
| Promoter Regions, Genetic | 46 | 2019 | 5785 | 1.140 |
Why?
|
| Protein Folding | 14 | 2012 | 867 | 1.130 |
Why?
|
| Osteogenesis | 12 | 2018 | 1271 | 1.120 |
Why?
|
| Immunity | 5 | 2019 | 998 | 1.120 |
Why?
|
| Signal Transduction | 46 | 2021 | 23376 | 1.080 |
Why?
|
| Killer Cells, Natural | 16 | 2022 | 2203 | 1.060 |
Why?
|
| CD4-Positive T-Lymphocytes | 37 | 2015 | 4353 | 1.040 |
Why?
|
| Interleukins | 6 | 2021 | 785 | 1.000 |
Why?
|
| Receptors, Antigen, T-Cell | 21 | 2017 | 2536 | 0.960 |
Why?
|
| Transcription, Genetic | 39 | 2021 | 7593 | 0.900 |
Why?
|
| Mice, Transgenic | 58 | 2017 | 9530 | 0.890 |
Why?
|
| Proto-Oncogene Proteins | 18 | 2011 | 4490 | 0.840 |
Why?
|
| Colitis, Ulcerative | 8 | 2014 | 1919 | 0.810 |
Why?
|
| Osteoclasts | 9 | 2017 | 711 | 0.790 |
Why?
|
| Cytokines | 31 | 2021 | 7343 | 0.790 |
Why?
|
| Stress, Physiological | 7 | 2011 | 1398 | 0.780 |
Why?
|
| Receptors, Interleukin | 3 | 2021 | 243 | 0.780 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 10 | 2012 | 491 | 0.770 |
Why?
|
| Bone Development | 6 | 2016 | 472 | 0.770 |
Why?
|
| Cell Lineage | 15 | 2020 | 2533 | 0.760 |
Why?
|
| Allergy and Immunology | 3 | 2015 | 175 | 0.740 |
Why?
|
| Midwifery | 1 | 2022 | 122 | 0.740 |
Why?
|
| Immune System | 8 | 2011 | 798 | 0.730 |
Why?
|
| Mice, Inbred C57BL | 75 | 2021 | 22023 | 0.720 |
Why?
|
| Erythropoiesis | 2 | 2021 | 682 | 0.710 |
Why?
|
| Blood Cells | 1 | 2021 | 305 | 0.680 |
Why?
|
| Erythroid Cells | 1 | 2021 | 235 | 0.670 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 6 | 2013 | 158 | 0.660 |
Why?
|
| Transcriptional Activation | 13 | 2010 | 1755 | 0.660 |
Why?
|
| Telomerase | 1 | 2024 | 746 | 0.650 |
Why?
|
| Molecular Sequence Data | 67 | 2013 | 17624 | 0.650 |
Why?
|
| Thymus Gland | 16 | 2011 | 1247 | 0.640 |
Why?
|
| Base Sequence | 61 | 2020 | 12446 | 0.640 |
Why?
|
| Cells, Cultured | 40 | 2021 | 18957 | 0.640 |
Why?
|
| Homeostasis | 10 | 2011 | 3306 | 0.630 |
Why?
|
| T-Lymphocyte Subsets | 21 | 2013 | 1810 | 0.630 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 1 | 2024 | 502 | 0.620 |
Why?
|
| Trans-Activators | 16 | 2005 | 2860 | 0.620 |
Why?
|
| Mice, Mutant Strains | 20 | 2013 | 1753 | 0.610 |
Why?
|
| Genes, myc | 2 | 2019 | 395 | 0.610 |
Why?
|
| T-Lymphocytes, Cytotoxic | 12 | 2006 | 1765 | 0.580 |
Why?
|
| Myelodysplastic Syndromes | 3 | 2024 | 1394 | 0.580 |
Why?
|
| Interleukin-13 | 4 | 2012 | 371 | 0.580 |
Why?
|
| Cell Line | 60 | 2017 | 15620 | 0.570 |
Why?
|
| Cartilage | 4 | 2010 | 806 | 0.570 |
Why?
|
| Bone and Bones | 10 | 2018 | 2560 | 0.560 |
Why?
|
| Hybridomas | 20 | 1990 | 442 | 0.550 |
Why?
|
| Chondrocytes | 6 | 2015 | 791 | 0.540 |
Why?
|
| Biomedical Research | 2 | 2022 | 3426 | 0.540 |
Why?
|
| HLA-D Antigens | 5 | 1997 | 134 | 0.530 |
Why?
|
| Antigen-Presenting Cells | 21 | 2001 | 967 | 0.530 |
Why?
|
| Endosomal Sorting Complexes Required for Transport | 1 | 2017 | 150 | 0.520 |
Why?
|
| Calcineurin | 4 | 2010 | 229 | 0.520 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 7 | 2013 | 2873 | 0.510 |
Why?
|
| CREB-Binding Protein | 3 | 2011 | 148 | 0.480 |
Why?
|
| Protein Unfolding | 2 | 2011 | 56 | 0.480 |
Why?
|
| Immunologic Deficiency Syndromes | 7 | 1996 | 557 | 0.470 |
Why?
|
| Gene Expression | 19 | 2016 | 7588 | 0.470 |
Why?
|
| Cell Cycle Proteins | 2 | 2024 | 3446 | 0.460 |
Why?
|
| H-2 Antigens | 10 | 2007 | 358 | 0.460 |
Why?
|
| Proto-Oncogene Proteins c-maf | 11 | 2003 | 69 | 0.460 |
Why?
|
| Liver | 9 | 2011 | 7509 | 0.460 |
Why?
|
| Amino Acid Sequence | 35 | 2021 | 13451 | 0.450 |
Why?
|
| Intestines | 4 | 2014 | 1907 | 0.450 |
Why?
|
| Transfection | 31 | 2006 | 5781 | 0.440 |
Why?
|
| Proteins | 8 | 2011 | 6029 | 0.440 |
Why?
|
| Interleukin-17 | 5 | 2014 | 910 | 0.440 |
Why?
|
| HLA-DR Antigens | 9 | 1996 | 630 | 0.440 |
Why?
|
| Bone Resorption | 3 | 2018 | 720 | 0.440 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2014 | 140 | 0.430 |
Why?
|
| Major Histocompatibility Complex | 14 | 1997 | 928 | 0.420 |
Why?
|
| Ubiquitin-Protein Ligases | 7 | 2017 | 1889 | 0.420 |
Why?
|
| MAP Kinase Signaling System | 5 | 2013 | 1484 | 0.420 |
Why?
|
| Interleukin-2 | 13 | 2005 | 1889 | 0.420 |
Why?
|
| Autoimmune Diseases | 11 | 2014 | 2250 | 0.420 |
Why?
|
| Bone Morphogenetic Protein 7 | 2 | 2014 | 110 | 0.420 |
Why?
|
| Bone Marrow Cells | 6 | 2018 | 2414 | 0.410 |
Why?
|
| Enterobacteriaceae | 2 | 2010 | 172 | 0.410 |
Why?
|
| Rubinstein-Taybi Syndrome | 1 | 2011 | 2 | 0.400 |
Why?
|
| Membrane Glycoproteins | 11 | 2010 | 3707 | 0.400 |
Why?
|
| Trophoblasts | 2 | 2004 | 224 | 0.400 |
Why?
|
| Humans | 161 | 2024 | 760621 | 0.400 |
Why?
|
| Autophagy | 6 | 2012 | 1337 | 0.400 |
Why?
|
| Inflammation | 16 | 2015 | 10756 | 0.390 |
Why?
|
| Lymphoid Tissue | 5 | 2003 | 445 | 0.390 |
Why?
|
| Autoimmunity | 6 | 2014 | 1370 | 0.390 |
Why?
|
| Anemia | 1 | 2021 | 1511 | 0.380 |
Why?
|
| Hyperparathyroidism, Secondary | 1 | 2012 | 125 | 0.380 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 4 | 2010 | 828 | 0.380 |
Why?
|
| Immunologic Memory | 11 | 2022 | 1354 | 0.380 |
Why?
|
| Antibodies, Neutralizing | 1 | 2021 | 1933 | 0.380 |
Why?
|
| Early Growth Response Protein 2 | 2 | 2009 | 25 | 0.370 |
Why?
|
| Melanoma, Experimental | 2 | 2019 | 562 | 0.370 |
Why?
|
| Proinsulin | 1 | 2011 | 135 | 0.370 |
Why?
|
| Proteus mirabilis | 1 | 2010 | 25 | 0.370 |
Why?
|
| Bone Morphogenetic Protein 2 | 2 | 2014 | 342 | 0.370 |
Why?
|
| Growth Plate | 3 | 2015 | 274 | 0.360 |
Why?
|
| Fetal Therapies | 1 | 2011 | 101 | 0.360 |
Why?
|
| Dwarfism | 1 | 2011 | 137 | 0.360 |
Why?
|
| Chromosomes, Mammalian | 1 | 2011 | 146 | 0.360 |
Why?
|
| DNA | 22 | 2022 | 7233 | 0.360 |
Why?
|
| Lymphocytes | 7 | 2007 | 2611 | 0.360 |
Why?
|
| Hand Deformities, Congenital | 1 | 2011 | 174 | 0.360 |
Why?
|
| Eosinophils | 1 | 2015 | 944 | 0.350 |
Why?
|
| Apoptosis | 18 | 2015 | 9501 | 0.350 |
Why?
|
| Microbial Interactions | 1 | 2010 | 74 | 0.350 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2014 | 621 | 0.350 |
Why?
|
| Gene Targeting | 11 | 2012 | 839 | 0.350 |
Why?
|
| Tularemia | 1 | 2010 | 42 | 0.350 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2010 | 144 | 0.340 |
Why?
|
| Spleen | 21 | 2015 | 2298 | 0.340 |
Why?
|
| Francisella tularensis | 1 | 2010 | 62 | 0.340 |
Why?
|
| Periodicals as Topic | 2 | 2011 | 1469 | 0.340 |
Why?
|
| Antigen Presentation | 5 | 2007 | 1254 | 0.340 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 5 | 2017 | 1407 | 0.340 |
Why?
|
| RNA, Messenger | 27 | 2012 | 12766 | 0.330 |
Why?
|
| Nervous System | 2 | 2009 | 543 | 0.330 |
Why?
|
| Bone Morphogenetic Protein Receptors | 1 | 2009 | 46 | 0.330 |
Why?
|
| Cell Biology | 1 | 2010 | 90 | 0.330 |
Why?
|
| Cherubism | 1 | 2008 | 15 | 0.320 |
Why?
|
| Intestinal Mucosa | 8 | 2015 | 3022 | 0.320 |
Why?
|
| Disease Models, Animal | 23 | 2021 | 18137 | 0.320 |
Why?
|
| Mutation | 35 | 2022 | 29932 | 0.320 |
Why?
|
| Apoptosis Regulatory Proteins | 3 | 2011 | 1135 | 0.320 |
Why?
|
| Feedback, Physiological | 1 | 2011 | 476 | 0.320 |
Why?
|
| Membrane Proteins | 12 | 2018 | 7850 | 0.310 |
Why?
|
| Klebsiella pneumoniae | 1 | 2010 | 255 | 0.310 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2010 | 351 | 0.310 |
Why?
|
| Oligodeoxyribonucleotides | 5 | 2005 | 778 | 0.310 |
Why?
|
| Microscopy, Electron, Transmission | 4 | 2017 | 697 | 0.310 |
Why?
|
| Receptors, Cytokine | 1 | 2009 | 258 | 0.310 |
Why?
|
| Gastroenteritis | 1 | 2010 | 237 | 0.300 |
Why?
|
| Osteoprotegerin | 1 | 2008 | 177 | 0.300 |
Why?
|
| Macrophages | 12 | 2015 | 5745 | 0.300 |
Why?
|
| Lipogenesis | 2 | 2012 | 210 | 0.300 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2011 | 378 | 0.290 |
Why?
|
| Immune Tolerance | 4 | 2016 | 2299 | 0.290 |
Why?
|
| Fetus | 2 | 2022 | 1859 | 0.290 |
Why?
|
| Dietary Carbohydrates | 2 | 2009 | 892 | 0.290 |
Why?
|
| Lipid Metabolism | 3 | 2012 | 1902 | 0.290 |
Why?
|
| Transforming Growth Factor beta | 4 | 2010 | 1959 | 0.290 |
Why?
|
| Candidiasis | 1 | 2010 | 363 | 0.290 |
Why?
|
| Amyotrophic Lateral Sclerosis | 2 | 2009 | 1463 | 0.290 |
Why?
|
| Women | 1 | 2009 | 225 | 0.290 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2010 | 642 | 0.290 |
Why?
|
| Hematopoiesis | 2 | 2016 | 2050 | 0.290 |
Why?
|
| Asthma | 9 | 2011 | 6172 | 0.290 |
Why?
|
| Flow Cytometry | 20 | 2015 | 5870 | 0.280 |
Why?
|
| Cell Division | 11 | 2004 | 4463 | 0.280 |
Why?
|
| CpG Islands | 5 | 2020 | 1221 | 0.280 |
Why?
|
| Antigens, Surface | 10 | 1993 | 1608 | 0.280 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 9 | 2015 | 4573 | 0.280 |
Why?
|
| Mycoses | 1 | 2010 | 387 | 0.280 |
Why?
|
| Heat-Shock Response | 1 | 2008 | 179 | 0.280 |
Why?
|
| Cloning, Molecular | 16 | 2001 | 4169 | 0.270 |
Why?
|
| Natural Killer T-Cells | 2 | 2010 | 311 | 0.270 |
Why?
|
| Epitopes | 14 | 2021 | 2503 | 0.270 |
Why?
|
| Science | 1 | 2009 | 239 | 0.270 |
Why?
|
| History, 21st Century | 3 | 2021 | 1575 | 0.270 |
Why?
|
| Tumor Microenvironment | 2 | 2017 | 3844 | 0.270 |
Why?
|
| GATA3 Transcription Factor | 7 | 2009 | 152 | 0.270 |
Why?
|
| CD8-Positive T-Lymphocytes | 11 | 2009 | 4550 | 0.270 |
Why?
|
| Exocrine Glands | 1 | 2005 | 46 | 0.260 |
Why?
|
| Prions | 1 | 2008 | 179 | 0.260 |
Why?
|
| Lentivirus | 2 | 2013 | 506 | 0.260 |
Why?
|
| Faculty | 1 | 2009 | 383 | 0.260 |
Why?
|
| Antigens, CD | 9 | 2011 | 4000 | 0.250 |
Why?
|
| Cytotoxicity, Immunologic | 8 | 2019 | 1351 | 0.250 |
Why?
|
| Inflammatory Bowel Diseases | 6 | 2015 | 2421 | 0.250 |
Why?
|
| Carrier Proteins | 5 | 2011 | 4938 | 0.250 |
Why?
|
| Research Personnel | 1 | 2010 | 582 | 0.250 |
Why?
|
| Organ Size | 3 | 2016 | 2254 | 0.250 |
Why?
|
| Cell Movement | 8 | 2010 | 5206 | 0.250 |
Why?
|
| Fibroblasts | 9 | 2024 | 4090 | 0.250 |
Why?
|
| Interleukin-5 | 6 | 2005 | 268 | 0.250 |
Why?
|
| Antifungal Agents | 1 | 2010 | 749 | 0.250 |
Why?
|
| Adoptive Transfer | 6 | 2009 | 822 | 0.250 |
Why?
|
| Binding Sites | 16 | 2016 | 6048 | 0.240 |
Why?
|
| Protein-Arginine N-Methyltransferases | 2 | 2010 | 131 | 0.240 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2008 | 409 | 0.240 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2010 | 841 | 0.240 |
Why?
|
| Mice, Inbred Strains | 26 | 1994 | 1763 | 0.240 |
Why?
|
| History, 20th Century | 3 | 2021 | 2773 | 0.240 |
Why?
|
| Multienzyme Complexes | 2 | 2009 | 666 | 0.240 |
Why?
|
| Transcription Factor RelA | 1 | 2005 | 251 | 0.240 |
Why?
|
| Histocompatibility Antigens | 4 | 1993 | 467 | 0.240 |
Why?
|
| Receptors, Tumor Necrosis Factor | 3 | 2002 | 585 | 0.240 |
Why?
|
| Insulin | 5 | 2011 | 6597 | 0.240 |
Why?
|
| Proto-Oncogene Proteins c-jun | 2 | 2004 | 285 | 0.230 |
Why?
|
| Gene Expression Regulation, Developmental | 7 | 2016 | 3604 | 0.230 |
Why?
|
| Th17 Cells | 1 | 2010 | 787 | 0.230 |
Why?
|
| Histocompatibility Antigens Class I | 7 | 2005 | 1355 | 0.230 |
Why?
|
| Repressor Proteins | 7 | 2011 | 2981 | 0.230 |
Why?
|
| NF-kappa B | 5 | 2021 | 2488 | 0.230 |
Why?
|
| Primary Ovarian Insufficiency | 1 | 2004 | 105 | 0.230 |
Why?
|
| Bone Remodeling | 1 | 2007 | 580 | 0.230 |
Why?
|
| Universities | 1 | 2009 | 992 | 0.220 |
Why?
|
| Musculoskeletal Diseases | 1 | 2010 | 595 | 0.220 |
Why?
|
| HEK293 Cells | 6 | 2021 | 4264 | 0.220 |
Why?
|
| Fatty Acids | 2 | 2009 | 1804 | 0.220 |
Why?
|
| Lymphoproliferative Disorders | 2 | 2004 | 533 | 0.220 |
Why?
|
| Arthritis, Experimental | 1 | 2006 | 291 | 0.220 |
Why?
|
| RANK Ligand | 4 | 2017 | 318 | 0.220 |
Why?
|
| Recombinant Proteins | 12 | 2018 | 6538 | 0.220 |
Why?
|
| Cytoplasm | 7 | 2013 | 1516 | 0.220 |
Why?
|
| Protein Binding | 11 | 2016 | 9335 | 0.220 |
Why?
|
| Leishmania major | 3 | 2002 | 59 | 0.220 |
Why?
|
| Sarcoma, Experimental | 5 | 1997 | 117 | 0.220 |
Why?
|
| Lymphocyte Subsets | 2 | 2004 | 310 | 0.220 |
Why?
|
| Gene Transfer Techniques | 2 | 2008 | 1204 | 0.220 |
Why?
|
| RNA | 5 | 2008 | 2722 | 0.210 |
Why?
|
| Activins | 1 | 2004 | 211 | 0.210 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 7 | 1993 | 788 | 0.210 |
Why?
|
| Genes | 5 | 1995 | 1845 | 0.210 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2003 | 189 | 0.210 |
Why?
|
| Recombinant Fusion Proteins | 10 | 2005 | 3735 | 0.210 |
Why?
|
| Down-Regulation | 6 | 2008 | 2913 | 0.210 |
Why?
|
| Tumor Cells, Cultured | 14 | 2003 | 6131 | 0.210 |
Why?
|
| Mitogen-Activated Protein Kinase 14 | 2 | 2014 | 29 | 0.210 |
Why?
|
| Immune System Phenomena | 2 | 2014 | 17 | 0.210 |
Why?
|
| Quantitative Trait Loci | 1 | 2011 | 2101 | 0.210 |
Why?
|
| Communicable Diseases | 1 | 2011 | 878 | 0.210 |
Why?
|
| Crosses, Genetic | 9 | 2003 | 751 | 0.210 |
Why?
|
| Metabolic Diseases | 1 | 2009 | 686 | 0.210 |
Why?
|
| Nerve Degeneration | 1 | 2007 | 748 | 0.210 |
Why?
|
| Arginine | 3 | 2010 | 934 | 0.210 |
Why?
|
| Adaptive Immunity | 2 | 2020 | 726 | 0.210 |
Why?
|
| Lymphocyte Culture Test, Mixed | 12 | 1999 | 516 | 0.210 |
Why?
|
| Ovarian Neoplasms | 2 | 2018 | 4878 | 0.200 |
Why?
|
| Lipids | 2 | 2012 | 3336 | 0.200 |
Why?
|
| Motor Neurons | 1 | 2007 | 865 | 0.200 |
Why?
|
| Smad3 Protein | 2 | 2017 | 167 | 0.200 |
Why?
|
| Mutagenesis, Site-Directed | 5 | 2004 | 1693 | 0.200 |
Why?
|
| Cell Survival | 6 | 2019 | 5797 | 0.200 |
Why?
|
| Prostaglandins E | 3 | 1994 | 169 | 0.200 |
Why?
|
| Serine | 1 | 2005 | 830 | 0.190 |
Why?
|
| Leishmaniasis, Cutaneous | 3 | 2002 | 136 | 0.190 |
Why?
|
| Neoplasm Metastasis | 3 | 2018 | 4902 | 0.190 |
Why?
|
| Proto-Oncogenes | 2 | 1999 | 320 | 0.190 |
Why?
|
| Phosphorylation | 9 | 2016 | 8313 | 0.190 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 5 | 2010 | 345 | 0.190 |
Why?
|
| Osteochondrodysplasias | 2 | 2015 | 182 | 0.190 |
Why?
|
| Gene Deletion | 6 | 2015 | 2668 | 0.190 |
Why?
|
| Lymphoma, T-Cell | 1 | 2003 | 305 | 0.190 |
Why?
|
| Proto-Oncogene Proteins c-vav | 1 | 2021 | 91 | 0.190 |
Why?
|
| RNA-Directed DNA Polymerase | 1 | 2021 | 224 | 0.190 |
Why?
|
| Myelopoiesis | 1 | 2021 | 134 | 0.190 |
Why?
|
| Lymphocyte Cooperation | 6 | 1996 | 113 | 0.180 |
Why?
|
| Molecular Chaperones | 3 | 2006 | 752 | 0.180 |
Why?
|
| RNA Splicing | 7 | 2012 | 915 | 0.180 |
Why?
|
| Transcription Factor AP-1 | 3 | 2001 | 321 | 0.180 |
Why?
|
| Phospholipases A | 1 | 2001 | 204 | 0.180 |
Why?
|
| Immunoglobulin Class Switching | 1 | 2002 | 289 | 0.180 |
Why?
|
| Skin Transplantation | 8 | 2008 | 1083 | 0.180 |
Why?
|
| 3T3 Cells | 4 | 2003 | 1085 | 0.180 |
Why?
|
| Immunoprecipitation | 2 | 2017 | 877 | 0.180 |
Why?
|
| Health Care Reform | 1 | 2009 | 1245 | 0.180 |
Why?
|
| K562 Cells | 1 | 2021 | 640 | 0.170 |
Why?
|
| Tunicamycin | 4 | 2010 | 108 | 0.170 |
Why?
|
| Cell Line, Tumor | 7 | 2021 | 16939 | 0.170 |
Why?
|
| HLA-DQ Antigens | 2 | 1997 | 211 | 0.170 |
Why?
|
| Lipopolysaccharides | 8 | 2010 | 2209 | 0.170 |
Why?
|
| Autoantigens | 5 | 1999 | 877 | 0.170 |
Why?
|
| Mitochondria | 4 | 2019 | 3600 | 0.170 |
Why?
|
| Stem Cells | 8 | 2015 | 3523 | 0.170 |
Why?
|
| Bone Density | 3 | 2010 | 3534 | 0.170 |
Why?
|
| Immunity, Mucosal | 2 | 2002 | 482 | 0.170 |
Why?
|
| Cyclic AMP | 3 | 1994 | 1456 | 0.170 |
Why?
|
| Zinc Fingers | 3 | 2007 | 568 | 0.170 |
Why?
|
| Receptors, Interleukin-4 | 3 | 2012 | 64 | 0.170 |
Why?
|
| Cyclosporine | 5 | 2010 | 777 | 0.170 |
Why?
|
| Immunoglobulins | 5 | 2005 | 859 | 0.170 |
Why?
|
| Antibodies, Blocking | 2 | 1996 | 242 | 0.170 |
Why?
|
| Crystallins | 1 | 1999 | 75 | 0.170 |
Why?
|
| Clone Cells | 12 | 2005 | 1660 | 0.160 |
Why?
|
| Neoplasms | 4 | 2021 | 22072 | 0.160 |
Why?
|
| Abortion, Spontaneous | 1 | 2004 | 530 | 0.160 |
Why?
|
| MicroRNAs | 1 | 2015 | 3790 | 0.160 |
Why?
|
| Mycobacterium | 1 | 2020 | 250 | 0.160 |
Why?
|
| Gout | 1 | 2006 | 620 | 0.160 |
Why?
|
| Lymphokines | 6 | 1991 | 927 | 0.160 |
Why?
|
| Tetradecanoylphorbol Acetate | 4 | 2004 | 818 | 0.160 |
Why?
|
| Graft Rejection | 10 | 2009 | 4426 | 0.160 |
Why?
|
| Blotting, Western | 7 | 2012 | 5039 | 0.160 |
Why?
|
| Dinoprostone | 3 | 2019 | 598 | 0.160 |
Why?
|
| MAP Kinase Kinase Kinase 2 | 2 | 2016 | 9 | 0.160 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 10 | 2021 | 801 | 0.160 |
Why?
|
| Models, Immunological | 4 | 2009 | 513 | 0.160 |
Why?
|
| Cell Adhesion Molecules | 4 | 2007 | 1602 | 0.160 |
Why?
|
| Bone Regeneration | 2 | 2015 | 432 | 0.160 |
Why?
|
| Hematopoietic Stem Cells | 4 | 2021 | 3387 | 0.160 |
Why?
|
| Genome-Wide Association Study | 3 | 2012 | 12626 | 0.160 |
Why?
|
| Colon | 4 | 2015 | 1788 | 0.160 |
Why?
|
| Ovalbumin | 4 | 2009 | 674 | 0.160 |
Why?
|
| Fibroblast Growth Factors | 1 | 2004 | 869 | 0.160 |
Why?
|
| Sialoglycoproteins | 3 | 2018 | 315 | 0.160 |
Why?
|
| Up-Regulation | 8 | 2012 | 4122 | 0.160 |
Why?
|
| RNA Stability | 2 | 2012 | 333 | 0.160 |
Why?
|
| Cancer Care Facilities | 1 | 2021 | 424 | 0.150 |
Why?
|
| Chondrogenesis | 1 | 2000 | 239 | 0.150 |
Why?
|
| Telomere | 1 | 2024 | 933 | 0.150 |
Why?
|
| Genetic Vectors | 1 | 2008 | 3380 | 0.150 |
Why?
|
| Mice, Inbred C3H | 8 | 2010 | 915 | 0.150 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2011 | 687 | 0.150 |
Why?
|
| Cell Line, Transformed | 5 | 2002 | 869 | 0.150 |
Why?
|
| HIV-1 | 1 | 2015 | 6849 | 0.150 |
Why?
|
| Triglycerides | 3 | 2011 | 2476 | 0.150 |
Why?
|
| Immunoglobulin G | 5 | 2002 | 4541 | 0.150 |
Why?
|
| Tumor Escape | 2 | 2018 | 370 | 0.150 |
Why?
|
| Chemokines | 3 | 2014 | 962 | 0.150 |
Why?
|
| National Institutes of Health (U.S.) | 2 | 2015 | 791 | 0.140 |
Why?
|
| Mesenchymal Stem Cells | 5 | 2013 | 1634 | 0.140 |
Why?
|
| Skull | 3 | 2012 | 815 | 0.140 |
Why?
|
| Tissue Culture Techniques | 2 | 2015 | 290 | 0.140 |
Why?
|
| Neutrophils | 1 | 2010 | 3767 | 0.140 |
Why?
|
| Protein Denaturation | 3 | 2008 | 242 | 0.140 |
Why?
|
| Embryonic and Fetal Development | 2 | 2000 | 420 | 0.140 |
Why?
|
| Neurodegenerative Diseases | 3 | 2013 | 1084 | 0.140 |
Why?
|
| Activating Transcription Factor 6 | 2 | 2009 | 29 | 0.140 |
Why?
|
| HIV Infections | 2 | 2015 | 17165 | 0.140 |
Why?
|
| Hodgkin Disease | 1 | 2005 | 1378 | 0.140 |
Why?
|
| Enterotoxins | 3 | 1994 | 366 | 0.140 |
Why?
|
| Cartilage, Articular | 2 | 2015 | 1091 | 0.140 |
Why?
|
| Oxidative Phosphorylation | 1 | 2019 | 495 | 0.140 |
Why?
|
| Skin | 3 | 2008 | 4466 | 0.140 |
Why?
|
| Listeriosis | 2 | 2010 | 148 | 0.140 |
Why?
|
| Lens, Crystalline | 1 | 1999 | 388 | 0.140 |
Why?
|
| Receptors, Interferon | 2 | 2009 | 116 | 0.140 |
Why?
|
| Cell Nucleus | 9 | 2008 | 2907 | 0.140 |
Why?
|
| Autoantibodies | 4 | 2002 | 2118 | 0.140 |
Why?
|
| Gene Silencing | 3 | 2014 | 1513 | 0.140 |
Why?
|
| Female | 52 | 2022 | 391270 | 0.140 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 6 | 2010 | 3775 | 0.140 |
Why?
|
| Activating Transcription Factor 2 | 5 | 2001 | 45 | 0.140 |
Why?
|
| Lymphoma | 12 | 1996 | 1898 | 0.140 |
Why?
|
| Hematopoiesis, Extramedullary | 1 | 1996 | 53 | 0.140 |
Why?
|
| Protein Structure, Tertiary | 6 | 2013 | 3800 | 0.140 |
Why?
|
| Osteoporosis | 4 | 2013 | 1600 | 0.130 |
Why?
|
| Cell Proliferation | 8 | 2015 | 10446 | 0.130 |
Why?
|
| Leucine Zippers | 1 | 1996 | 116 | 0.130 |
Why?
|
| Heart Valves | 1 | 1998 | 285 | 0.130 |
Why?
|
| Nephritis | 2 | 1994 | 149 | 0.130 |
Why?
|
| Lymphocyte Depletion | 6 | 1996 | 602 | 0.130 |
Why?
|
| Leukemia, Myeloid, Acute | 2 | 2022 | 3602 | 0.130 |
Why?
|
| DNA Primers | 6 | 2012 | 2819 | 0.130 |
Why?
|
| Mice, Inbred CBA | 6 | 2007 | 436 | 0.130 |
Why?
|
| Enhancer Elements, Genetic | 5 | 2016 | 1356 | 0.130 |
Why?
|
| Diabetes Mellitus, Type 1 | 6 | 2009 | 3455 | 0.130 |
Why?
|
| Time Factors | 15 | 2011 | 40165 | 0.130 |
Why?
|
| Phenotype | 17 | 2012 | 16546 | 0.130 |
Why?
|
| Growth Substances | 3 | 1986 | 768 | 0.130 |
Why?
|
| DNA, Complementary | 6 | 2005 | 1991 | 0.130 |
Why?
|
| Receptors, Calcitriol | 2 | 2017 | 359 | 0.130 |
Why?
|
| Nucleic Acid Hybridization | 4 | 1991 | 1304 | 0.130 |
Why?
|
| Transcription Factor CHOP | 3 | 2012 | 68 | 0.130 |
Why?
|
| STAT6 Transcription Factor | 4 | 2004 | 193 | 0.130 |
Why?
|
| Superoxide Dismutase | 2 | 2009 | 594 | 0.130 |
Why?
|
| Enzyme Activation | 2 | 2012 | 3602 | 0.130 |
Why?
|
| Scleroderma, Systemic | 2 | 2012 | 344 | 0.130 |
Why?
|
| Granulocyte Precursor Cells | 1 | 2015 | 49 | 0.130 |
Why?
|
| Macromolecular Substances | 8 | 1996 | 1433 | 0.130 |
Why?
|
| Endothelium | 1 | 2018 | 764 | 0.130 |
Why?
|
| Mice, Inbred NZB | 4 | 2009 | 57 | 0.130 |
Why?
|
| In Situ Nick-End Labeling | 2 | 2007 | 613 | 0.130 |
Why?
|
| Antigens | 6 | 2003 | 1447 | 0.130 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 1 | 2015 | 102 | 0.120 |
Why?
|
| Muramidase | 4 | 2008 | 169 | 0.120 |
Why?
|
| Ameloblasts | 1 | 2014 | 17 | 0.120 |
Why?
|
| Tumor Necrosis Factor-alpha | 8 | 2010 | 4357 | 0.120 |
Why?
|
| Organ Specificity | 6 | 2001 | 1955 | 0.120 |
Why?
|
| Interleukin-10 | 4 | 2005 | 1175 | 0.120 |
Why?
|
| Cell Polarity | 3 | 2004 | 638 | 0.120 |
Why?
|
| Odontogenesis | 1 | 2014 | 65 | 0.120 |
Why?
|
| Bronchial Hyperreactivity | 3 | 2008 | 302 | 0.120 |
Why?
|
| Dental Enamel | 1 | 2014 | 60 | 0.120 |
Why?
|
| Immunohistochemistry | 9 | 2013 | 11071 | 0.120 |
Why?
|
| Heart Defects, Congenital | 1 | 2011 | 4673 | 0.120 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinase 2 | 1 | 2014 | 32 | 0.120 |
Why?
|
| Genes, Reporter | 5 | 2008 | 1529 | 0.120 |
Why?
|
| Immunotherapy, Adoptive | 2 | 2022 | 1454 | 0.120 |
Why?
|
| Lipid Peroxidation | 1 | 2015 | 271 | 0.120 |
Why?
|
| Receptors, Chemokine | 3 | 2006 | 655 | 0.120 |
Why?
|
| Calcification, Physiologic | 1 | 2015 | 170 | 0.120 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2021 | 2919 | 0.120 |
Why?
|
| Blotting, Northern | 6 | 1996 | 1543 | 0.110 |
Why?
|
| Myeloid Differentiation Factor 88 | 2 | 2010 | 581 | 0.110 |
Why?
|
| Protein Conformation | 8 | 2009 | 3969 | 0.110 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2017 | 454 | 0.110 |
Why?
|
| Mice, Inbred A | 6 | 1997 | 246 | 0.110 |
Why?
|
| Regulatory Elements, Transcriptional | 2 | 2012 | 183 | 0.110 |
Why?
|
| Immunoblotting | 1 | 2017 | 1649 | 0.110 |
Why?
|
| Chagas Disease | 1 | 1996 | 167 | 0.110 |
Why?
|
| Drosophila Proteins | 2 | 2009 | 1699 | 0.110 |
Why?
|
| Incisor | 1 | 2014 | 174 | 0.110 |
Why?
|
| Immunity, Cellular | 5 | 2011 | 1557 | 0.110 |
Why?
|
| Pregnancy | 6 | 2022 | 29749 | 0.110 |
Why?
|
| Lung | 6 | 2024 | 9994 | 0.110 |
Why?
|
| Gene Regulatory Networks | 2 | 2014 | 1741 | 0.110 |
Why?
|
| Immunophenotyping | 5 | 2010 | 1871 | 0.110 |
Why?
|
| Fas Ligand Protein | 3 | 2000 | 215 | 0.110 |
Why?
|
| Caspase 3 | 2 | 2013 | 731 | 0.110 |
Why?
|
| Receptors, Immunologic | 4 | 2018 | 1411 | 0.110 |
Why?
|
| Severe Combined Immunodeficiency | 1 | 1996 | 226 | 0.110 |
Why?
|
| Metalloendopeptidases | 2 | 1994 | 393 | 0.110 |
Why?
|
| eIF-2 Kinase | 3 | 2009 | 144 | 0.110 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2017 | 1974 | 0.110 |
Why?
|
| beta Catenin | 2 | 2016 | 1043 | 0.110 |
Why?
|
| Endopeptidases | 1 | 2017 | 772 | 0.110 |
Why?
|
| Antibodies, Monoclonal | 18 | 2009 | 9185 | 0.110 |
Why?
|
| Polymerase Chain Reaction | 8 | 2002 | 6068 | 0.110 |
Why?
|
| Cell Hypoxia | 2 | 2014 | 658 | 0.110 |
Why?
|
| Ubiquitination | 3 | 2017 | 1008 | 0.110 |
Why?
|
| Endocrine Glands | 1 | 1993 | 101 | 0.110 |
Why?
|
| Amino Acid Substitution | 1 | 1997 | 1737 | 0.110 |
Why?
|
| Transgenes | 5 | 2008 | 1006 | 0.110 |
Why?
|
| Cholesterol | 4 | 2012 | 2924 | 0.110 |
Why?
|
| Genetic Drift | 1 | 2012 | 41 | 0.100 |
Why?
|
| Interleukin-23 | 1 | 2014 | 197 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 5 | 2 | 1991 | 385 | 0.100 |
Why?
|
| Immunoglobulin M | 6 | 2009 | 1529 | 0.100 |
Why?
|
| Restriction Mapping | 4 | 1999 | 852 | 0.100 |
Why?
|
| RNA Polymerase II | 2 | 2014 | 537 | 0.100 |
Why?
|
| Gene Expression Profiling | 7 | 2016 | 9411 | 0.100 |
Why?
|
| Chromatin | 3 | 2020 | 2938 | 0.100 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2016 | 599 | 0.100 |
Why?
|
| Cell Death | 3 | 2013 | 1672 | 0.100 |
Why?
|
| Adipocytes | 1 | 1998 | 1179 | 0.100 |
Why?
|
| TNF Receptor-Associated Factor 2 | 2 | 2002 | 57 | 0.100 |
Why?
|
| Bone Diseases | 1 | 2015 | 419 | 0.100 |
Why?
|
| Genitalia, Male | 1 | 2011 | 87 | 0.100 |
Why?
|
| Delivery of Health Care | 1 | 2009 | 5325 | 0.100 |
Why?
|
| Genetic Variation | 4 | 2012 | 6551 | 0.100 |
Why?
|
| Pancreas, Exocrine | 1 | 2011 | 48 | 0.090 |
Why?
|
| Goosecoid Protein | 1 | 2010 | 9 | 0.090 |
Why?
|
| Hypertriglyceridemia | 2 | 2011 | 316 | 0.090 |
Why?
|
| RNA, Small Interfering | 5 | 2013 | 3442 | 0.090 |
Why?
|
| Colitis | 3 | 2015 | 1229 | 0.090 |
Why?
|
| Microbial Collagenase | 1 | 1991 | 113 | 0.090 |
Why?
|
| Leukocytes | 1 | 2019 | 2026 | 0.090 |
Why?
|
| Chief Cells, Gastric | 1 | 2010 | 4 | 0.090 |
Why?
|
| Genes, Dominant | 3 | 2003 | 863 | 0.090 |
Why?
|
| Endoplasmic Reticulum, Rough | 1 | 2010 | 21 | 0.090 |
Why?
|
| Coculture Techniques | 2 | 2012 | 1342 | 0.090 |
Why?
|
| Antigens, Ly | 4 | 1986 | 292 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 22 | 2 | 1993 | 346 | 0.090 |
Why?
|
| Disease Progression | 4 | 2018 | 13502 | 0.090 |
Why?
|
| cdc42 GTP-Binding Protein | 1 | 2011 | 187 | 0.090 |
Why?
|
| Ubiquitin-Protein Ligase Complexes | 1 | 2011 | 169 | 0.090 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2013 | 616 | 0.090 |
Why?
|
| Lymphocytic Choriomeningitis | 3 | 2003 | 139 | 0.090 |
Why?
|
| Insulin Resistance | 3 | 2011 | 3959 | 0.090 |
Why?
|
| Cholera Toxin | 1 | 2013 | 559 | 0.090 |
Why?
|
| Optic Nerve Injuries | 1 | 2012 | 147 | 0.090 |
Why?
|
| Hair Follicle | 2 | 2010 | 210 | 0.090 |
Why?
|
| Microscopy, Confocal | 2 | 2015 | 1972 | 0.090 |
Why?
|
| Cathepsin D | 1 | 1990 | 59 | 0.090 |
Why?
|
| Protein Splicing | 1 | 2010 | 16 | 0.090 |
Why?
|
| Host-Pathogen Interactions | 1 | 2019 | 1447 | 0.090 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 3 | 1998 | 221 | 0.090 |
Why?
|
| Structure-Activity Relationship | 7 | 1997 | 3084 | 0.090 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 4 | 2008 | 3804 | 0.090 |
Why?
|
| Immunosuppressive Agents | 5 | 2010 | 4166 | 0.090 |
Why?
|
| Chemokine CCL2 | 2 | 2012 | 605 | 0.090 |
Why?
|
| Caseins | 1 | 1990 | 103 | 0.090 |
Why?
|
| Interleukin-23 Subunit p19 | 1 | 2010 | 23 | 0.090 |
Why?
|
| Zymosan | 1 | 2010 | 136 | 0.090 |
Why?
|
| Gene Knock-In Techniques | 1 | 2011 | 419 | 0.090 |
Why?
|
| Bifidobacterium | 1 | 2010 | 98 | 0.090 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2013 | 383 | 0.090 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2013 | 1246 | 0.090 |
Why?
|
| Neurons | 4 | 2016 | 9426 | 0.090 |
Why?
|
| Receptors, Virus | 3 | 2010 | 639 | 0.090 |
Why?
|
| Tarsal Joints | 1 | 2010 | 32 | 0.090 |
Why?
|
| Hybrid Cells | 4 | 1997 | 422 | 0.090 |
Why?
|
| TNF Receptor-Associated Factor 6 | 1 | 2010 | 62 | 0.090 |
Why?
|
| Hepatocytes | 2 | 2008 | 1229 | 0.090 |
Why?
|
| Forelimb | 1 | 2010 | 115 | 0.090 |
Why?
|
| Lipopeptides | 1 | 2010 | 72 | 0.090 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2011 | 444 | 0.090 |
Why?
|
| Microscopy, Fluorescence | 1 | 2017 | 2651 | 0.090 |
Why?
|
| Kidney Tubules | 4 | 1993 | 449 | 0.090 |
Why?
|
| Plasmids | 4 | 2008 | 2275 | 0.090 |
Why?
|
| Arthritis | 2 | 2011 | 666 | 0.080 |
Why?
|
| Heat-Shock Proteins | 4 | 2011 | 795 | 0.080 |
Why?
|
| Egg Proteins, Dietary | 1 | 1989 | 6 | 0.080 |
Why?
|
| Hippocampus | 2 | 2016 | 3738 | 0.080 |
Why?
|
| Colorectal Neoplasms | 1 | 2009 | 6853 | 0.080 |
Why?
|
| Methylation | 3 | 2010 | 1082 | 0.080 |
Why?
|
| Smad Proteins | 1 | 2010 | 156 | 0.080 |
Why?
|
| Pneumonia | 1 | 2021 | 2131 | 0.080 |
Why?
|
| Oligonucleotide Probes | 4 | 1990 | 418 | 0.080 |
Why?
|
| Mice, Inbred MRL lpr | 1 | 2009 | 153 | 0.080 |
Why?
|
| Synovial Membrane | 2 | 1994 | 524 | 0.080 |
Why?
|
| Salivary Glands | 2 | 2005 | 229 | 0.080 |
Why?
|
| T-Lymphocytes, Regulatory | 4 | 2012 | 3075 | 0.080 |
Why?
|
| Lupus Erythematosus, Systemic | 2 | 2009 | 2159 | 0.080 |
Why?
|
| beta-Glucans | 1 | 2010 | 121 | 0.080 |
Why?
|
| Precipitin Tests | 3 | 2004 | 814 | 0.080 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2010 | 2506 | 0.080 |
Why?
|
| Male | 40 | 2021 | 359744 | 0.080 |
Why?
|
| Collagenases | 2 | 2003 | 221 | 0.080 |
Why?
|
| Chimera | 3 | 2004 | 453 | 0.080 |
Why?
|
| Gene Library | 4 | 1996 | 1060 | 0.080 |
Why?
|
| E-Selectin | 2 | 2005 | 576 | 0.080 |
Why?
|
| Pancreatic Diseases | 1 | 2011 | 343 | 0.080 |
Why?
|
| Bone Diseases, Developmental | 1 | 2010 | 131 | 0.080 |
Why?
|
| Sequence Homology, Nucleic Acid | 4 | 1990 | 1055 | 0.080 |
Why?
|
| Pain, Postoperative | 1 | 2019 | 1721 | 0.080 |
Why?
|
| Glycogen Synthase Kinase 3 | 2 | 2013 | 410 | 0.080 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2009 | 135 | 0.080 |
Why?
|
| Lymphoma, B-Cell | 4 | 2005 | 935 | 0.080 |
Why?
|
| Syndecan-1 | 1 | 2009 | 163 | 0.080 |
Why?
|
| Killer Cells, Lymphokine-Activated | 1 | 2008 | 42 | 0.080 |
Why?
|
| Isoantigens | 6 | 1985 | 552 | 0.080 |
Why?
|
| Osteoarthritis | 2 | 2013 | 1055 | 0.080 |
Why?
|
| Tissue Distribution | 2 | 2005 | 2262 | 0.080 |
Why?
|
| Enteritis | 1 | 2010 | 162 | 0.080 |
Why?
|
| Models, Biological | 7 | 2013 | 9467 | 0.080 |
Why?
|
| Progestins | 1 | 2010 | 302 | 0.080 |
Why?
|
| Abnormalities, Multiple | 1 | 1996 | 1415 | 0.080 |
Why?
|
| Genome | 1 | 2016 | 1739 | 0.080 |
Why?
|
| Joints | 1 | 2010 | 321 | 0.080 |
Why?
|
| Clonal Deletion | 2 | 1999 | 74 | 0.080 |
Why?
|
| Yeasts | 1 | 2009 | 279 | 0.080 |
Why?
|
| Craniofacial Abnormalities | 1 | 2010 | 315 | 0.080 |
Why?
|
| Myeloid Cells | 2 | 2019 | 820 | 0.080 |
Why?
|
| DNA Footprinting | 3 | 1996 | 97 | 0.080 |
Why?
|
| Anion Transport Proteins | 1 | 2008 | 141 | 0.080 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2010 | 348 | 0.070 |
Why?
|
| Multiple Myeloma | 2 | 2003 | 5130 | 0.070 |
Why?
|
| Forkhead Transcription Factors | 2 | 2012 | 1612 | 0.070 |
Why?
|
| STAT1 Transcription Factor | 2 | 2006 | 333 | 0.070 |
Why?
|
| Uterus | 1 | 2011 | 651 | 0.070 |
Why?
|
| Intracellular Fluid | 1 | 1988 | 201 | 0.070 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2011 | 1139 | 0.070 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2010 | 507 | 0.070 |
Why?
|
| Acetaminophen | 1 | 2012 | 553 | 0.070 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2011 | 568 | 0.070 |
Why?
|
| Milk | 1 | 2010 | 443 | 0.070 |
Why?
|
| Lipase | 1 | 1990 | 324 | 0.070 |
Why?
|
| Genes, Lethal | 2 | 2000 | 225 | 0.070 |
Why?
|
| Mice, Nude | 7 | 2010 | 3607 | 0.070 |
Why?
|
| Microtubules | 1 | 2013 | 1072 | 0.070 |
Why?
|
| Egg Proteins | 1 | 2007 | 57 | 0.070 |
Why?
|
| Carbohydrates | 1 | 2009 | 388 | 0.070 |
Why?
|
| Listeria monocytogenes | 2 | 2008 | 248 | 0.070 |
Why?
|
| Antiporters | 1 | 2008 | 278 | 0.070 |
Why?
|
| Polysaccharides, Bacterial | 1 | 2010 | 574 | 0.070 |
Why?
|
| Hepatitis | 1 | 2009 | 230 | 0.070 |
Why?
|
| Peptide Fragments | 3 | 2009 | 5125 | 0.070 |
Why?
|
| Disease Susceptibility | 2 | 2010 | 1791 | 0.070 |
Why?
|
| Candida albicans | 1 | 2010 | 374 | 0.070 |
Why?
|
| Cadherins | 1 | 2011 | 898 | 0.070 |
Why?
|
| Tissue Adhesions | 1 | 2008 | 222 | 0.070 |
Why?
|
| Career Mobility | 1 | 2009 | 258 | 0.070 |
Why?
|
| Antibody Formation | 4 | 2001 | 1400 | 0.070 |
Why?
|
| Animals, Newborn | 3 | 2017 | 2672 | 0.070 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2015 | 2197 | 0.070 |
Why?
|
| Sequence Homology, Amino Acid | 4 | 2010 | 2753 | 0.070 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2009 | 317 | 0.070 |
Why?
|
| Introns | 1 | 1989 | 978 | 0.070 |
Why?
|
| Blood Proteins | 1 | 1992 | 1173 | 0.070 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2021 | 2290 | 0.070 |
Why?
|
| Interferon Regulatory Factors | 2 | 2012 | 260 | 0.070 |
Why?
|
| Genetic Engineering | 1 | 2012 | 933 | 0.070 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 1996 | 1854 | 0.070 |
Why?
|
| Glycoproteins | 3 | 2005 | 2208 | 0.070 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 1989 | 415 | 0.070 |
Why?
|
| Graft Survival | 3 | 1998 | 3794 | 0.070 |
Why?
|
| Cell Communication | 3 | 2008 | 1653 | 0.070 |
Why?
|
| Sclerosis | 1 | 2007 | 210 | 0.070 |
Why?
|
| Neovascularization, Pathologic | 1 | 2017 | 2640 | 0.070 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2010 | 580 | 0.070 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2007 | 305 | 0.070 |
Why?
|
| Fructose | 1 | 2008 | 287 | 0.070 |
Why?
|
| Mast Cells | 2 | 2007 | 1390 | 0.070 |
Why?
|
| Adenocarcinoma | 1 | 2004 | 6315 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 7 | 2011 | 17790 | 0.070 |
Why?
|
| Body Fluids | 1 | 1988 | 319 | 0.070 |
Why?
|
| bcl-2 Homologous Antagonist-Killer Protein | 1 | 2006 | 71 | 0.070 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2018 | 8515 | 0.070 |
Why?
|
| NIH 3T3 Cells | 1 | 2008 | 670 | 0.070 |
Why?
|
| Epithelium | 5 | 1999 | 1605 | 0.070 |
Why?
|
| Memory | 1 | 2016 | 2179 | 0.070 |
Why?
|
| Probiotics | 1 | 2010 | 377 | 0.070 |
Why?
|
| Neuroprotective Agents | 1 | 2013 | 961 | 0.070 |
Why?
|
| Cardiovascular Diseases | 1 | 2012 | 15757 | 0.070 |
Why?
|
| Bleomycin | 1 | 2007 | 495 | 0.060 |
Why?
|
| Lymph Nodes | 7 | 2001 | 3486 | 0.060 |
Why?
|
| HLA-DP Antigens | 2 | 1998 | 28 | 0.060 |
Why?
|
| Leishmania donovani | 1 | 2006 | 68 | 0.060 |
Why?
|
| Retinal Ganglion Cells | 1 | 2012 | 806 | 0.060 |
Why?
|
| Neoplasm Invasiveness | 1 | 2014 | 3618 | 0.060 |
Why?
|
| Neoplasm Transplantation | 3 | 2018 | 2014 | 0.060 |
Why?
|
| Immunoglobulin mu-Chains | 1 | 2005 | 62 | 0.060 |
Why?
|
| Glucose | 3 | 2018 | 4351 | 0.060 |
Why?
|
| Casein Kinase I | 1 | 2005 | 46 | 0.060 |
Why?
|
| Salmonella Infections, Animal | 1 | 2005 | 61 | 0.060 |
Why?
|
| Crohn Disease | 3 | 2010 | 2275 | 0.060 |
Why?
|
| Green Fluorescent Proteins | 3 | 2013 | 2057 | 0.060 |
Why?
|
| Gene Dosage | 1 | 2010 | 1218 | 0.060 |
Why?
|
| Spermatozoa | 1 | 1990 | 631 | 0.060 |
Why?
|
| Smad7 Protein | 1 | 2005 | 40 | 0.060 |
Why?
|
| Staphylococcus aureus | 2 | 1994 | 1462 | 0.060 |
Why?
|
| Protein Biosynthesis | 6 | 2005 | 2105 | 0.060 |
Why?
|
| Immunoglobulin E | 3 | 2008 | 1484 | 0.060 |
Why?
|
| bcl-X Protein | 1 | 2007 | 413 | 0.060 |
Why?
|
| Bone Matrix | 1 | 2005 | 118 | 0.060 |
Why?
|
| Face | 1 | 2011 | 1017 | 0.060 |
Why?
|
| Leishmaniasis, Visceral | 1 | 2006 | 99 | 0.060 |
Why?
|
| Jurkat Cells | 2 | 2004 | 736 | 0.060 |
Why?
|
| Fibroblast Growth Factor 4 | 1 | 2004 | 28 | 0.060 |
Why?
|
| Bone Marrow Transplantation | 1 | 1993 | 2693 | 0.060 |
Why?
|
| Interleukin-12 | 3 | 2002 | 584 | 0.060 |
Why?
|
| Kidney Tubules, Proximal | 4 | 1991 | 382 | 0.060 |
Why?
|
| Huntington Disease | 1 | 2012 | 1141 | 0.060 |
Why?
|
| Lymphocyte Count | 2 | 1998 | 780 | 0.060 |
Why?
|
| Prejudice | 1 | 2009 | 563 | 0.060 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2006 | 282 | 0.060 |
Why?
|
| Aging | 6 | 2012 | 8651 | 0.060 |
Why?
|
| Mice, SCID | 4 | 2008 | 2627 | 0.060 |
Why?
|
| Homeodomain Proteins | 5 | 2011 | 2414 | 0.060 |
Why?
|
| Receptors, Prolactin | 1 | 2004 | 16 | 0.060 |
Why?
|
| Gene Knockdown Techniques | 1 | 2009 | 1617 | 0.060 |
Why?
|
| DNA, Neoplasm | 1 | 1990 | 1745 | 0.060 |
Why?
|
| Sequence Alignment | 2 | 2016 | 2176 | 0.060 |
Why?
|
| Vimentin | 1 | 2005 | 255 | 0.060 |
Why?
|
| Bronchoalveolar Lavage Fluid | 2 | 2008 | 748 | 0.060 |
Why?
|
| United States | 5 | 2021 | 72461 | 0.060 |
Why?
|
| Corpus Luteum | 1 | 2004 | 81 | 0.060 |
Why?
|
| Myocarditis | 2 | 2006 | 766 | 0.060 |
Why?
|
| Ubiquitin | 2 | 2006 | 838 | 0.060 |
Why?
|
| Transplantation Tolerance | 1 | 2009 | 605 | 0.060 |
Why?
|
| Genes, MHC Class I | 3 | 1993 | 240 | 0.060 |
Why?
|
| Mice, Inbred AKR | 2 | 1999 | 104 | 0.060 |
Why?
|
| Models, Molecular | 2 | 2016 | 5434 | 0.060 |
Why?
|
| Protease Inhibitors | 1 | 2008 | 755 | 0.060 |
Why?
|
| Golgi Apparatus | 1 | 2005 | 404 | 0.060 |
Why?
|
| Protein-Tyrosine Kinases | 3 | 2005 | 2418 | 0.060 |
Why?
|
| Glycolysis | 1 | 2008 | 828 | 0.060 |
Why?
|
| Biological Evolution | 1 | 2010 | 1074 | 0.060 |
Why?
|
| Microscopy, Electron | 1 | 2007 | 2558 | 0.060 |
Why?
|
| Graft vs Host Disease | 2 | 2012 | 3025 | 0.060 |
Why?
|
| Phosphotyrosine | 1 | 2005 | 456 | 0.060 |
Why?
|
| Dimerization | 1 | 2005 | 891 | 0.060 |
Why?
|
| Feces | 1 | 2010 | 1455 | 0.060 |
Why?
|
| Drug Delivery Systems | 1 | 2015 | 2221 | 0.060 |
Why?
|
| Pancreas | 2 | 2005 | 1677 | 0.060 |
Why?
|
| Immunoglobulin Heavy Chains | 2 | 2003 | 649 | 0.060 |
Why?
|
| Digestive System | 1 | 2004 | 244 | 0.060 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2011 | 1928 | 0.060 |
Why?
|
| Nerve Tissue Proteins | 2 | 2018 | 4407 | 0.060 |
Why?
|
| Insulin-Secreting Cells | 1 | 2011 | 907 | 0.060 |
Why?
|
| Boronic Acids | 1 | 2008 | 914 | 0.060 |
Why?
|
| Leupeptins | 1 | 2003 | 113 | 0.060 |
Why?
|
| HSP40 Heat-Shock Proteins | 1 | 2003 | 81 | 0.060 |
Why?
|
| Spinal Cord | 2 | 2009 | 1817 | 0.060 |
Why?
|
| Matrix Metalloproteinase 13 | 1 | 2003 | 102 | 0.060 |
Why?
|
| Genes, Regulator | 2 | 1995 | 374 | 0.050 |
Why?
|
| Chromosome Mapping | 5 | 1996 | 4625 | 0.050 |
Why?
|
| Salmonella typhimurium | 1 | 2005 | 344 | 0.050 |
Why?
|
| Bacteria | 1 | 2014 | 2199 | 0.050 |
Why?
|
| Pedigree | 2 | 2021 | 4578 | 0.050 |
Why?
|
| Calcitriol | 1 | 1984 | 297 | 0.050 |
Why?
|
| P-Selectin | 1 | 2005 | 599 | 0.050 |
Why?
|
| PPAR gamma | 1 | 2005 | 484 | 0.050 |
Why?
|
| Lupus Vulgaris | 1 | 2002 | 10 | 0.050 |
Why?
|
| Superantigens | 2 | 1994 | 127 | 0.050 |
Why?
|
| Fibrosarcoma | 1 | 2004 | 308 | 0.050 |
Why?
|
| In Situ Hybridization | 4 | 2010 | 1900 | 0.050 |
Why?
|
| Fetal Death | 1 | 2004 | 434 | 0.050 |
Why?
|
| Organelles | 1 | 2004 | 267 | 0.050 |
Why?
|
| Receptors, LDL | 1 | 2005 | 488 | 0.050 |
Why?
|
| Regeneration | 1 | 2011 | 1506 | 0.050 |
Why?
|
| RNA Interference | 2 | 2012 | 2846 | 0.050 |
Why?
|
| Apolipoprotein C-II | 2 | 2011 | 15 | 0.050 |
Why?
|
| X-Ray Microtomography | 2 | 2015 | 443 | 0.050 |
Why?
|
| Rats | 7 | 2013 | 23711 | 0.050 |
Why?
|
| Pyrazines | 1 | 2008 | 1199 | 0.050 |
Why?
|
| Longevity | 1 | 2009 | 1050 | 0.050 |
Why?
|
| HLA-A2 Antigen | 1 | 2022 | 211 | 0.050 |
Why?
|
| Dyslipidemias | 1 | 2009 | 895 | 0.050 |
Why?
|
| Collagen Type III | 1 | 2002 | 91 | 0.050 |
Why?
|
| Antigens, Differentiation, B-Lymphocyte | 2 | 1996 | 317 | 0.050 |
Why?
|
| Cell Adhesion | 2 | 2007 | 3094 | 0.050 |
Why?
|
| Hypertrophy | 1 | 2003 | 555 | 0.050 |
Why?
|
| Interferons | 1 | 2005 | 705 | 0.050 |
Why?
|
| Arthritis, Rheumatoid | 2 | 2001 | 3763 | 0.050 |
Why?
|
| Interferon-alpha | 1 | 2006 | 918 | 0.050 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2001 | 220 | 0.050 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2009 | 1313 | 0.050 |
Why?
|
| Kidney | 6 | 2015 | 7064 | 0.050 |
Why?
|
| Interleukin-6 | 2 | 2003 | 3215 | 0.050 |
Why?
|
| Transplantation, Homologous | 4 | 2009 | 4810 | 0.050 |
Why?
|
| Histone Deacetylases | 1 | 2005 | 718 | 0.050 |
Why?
|
| Enterovirus B, Human | 1 | 2001 | 47 | 0.050 |
Why?
|
| HeLa Cells | 3 | 2005 | 3105 | 0.050 |
Why?
|
| Choristoma | 1 | 2002 | 207 | 0.050 |
Why?
|
| National Health Programs | 1 | 2004 | 441 | 0.050 |
Why?
|
| Adaptation, Physiological | 1 | 2008 | 1296 | 0.050 |
Why?
|
| Coxsackievirus Infections | 1 | 2001 | 42 | 0.050 |
Why?
|
| Genetic Loci | 1 | 2010 | 2618 | 0.050 |
Why?
|
| Prostatic Neoplasms | 1 | 2004 | 11345 | 0.050 |
Why?
|
| Cysteine Endopeptidases | 1 | 2003 | 548 | 0.050 |
Why?
|
| Early Growth Response Protein 3 | 1 | 2000 | 10 | 0.040 |
Why?
|
| Mice, Inbred DBA | 3 | 1999 | 622 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-fos | 2 | 1995 | 586 | 0.040 |
Why?
|
| Polyomavirus | 1 | 2001 | 234 | 0.040 |
Why?
|
| Injections, Intraperitoneal | 1 | 2001 | 412 | 0.040 |
Why?
|
| Sequence Analysis | 1 | 2001 | 240 | 0.040 |
Why?
|
| Cytomegalovirus | 1 | 2005 | 755 | 0.040 |
Why?
|
| Arteriosclerosis | 1 | 2005 | 1064 | 0.040 |
Why?
|
| Neoplasm Proteins | 3 | 2003 | 3610 | 0.040 |
Why?
|
| Cell Fusion | 2 | 1996 | 293 | 0.040 |
Why?
|
| Glutamine | 2 | 2018 | 576 | 0.040 |
Why?
|
| Mycobacterium Infections | 1 | 2020 | 121 | 0.040 |
Why?
|
| Vascular Diseases | 1 | 2008 | 1182 | 0.040 |
Why?
|
| Embryo, Mammalian | 3 | 2010 | 1674 | 0.040 |
Why?
|
| Salivary Gland Neoplasms | 1 | 2004 | 304 | 0.040 |
Why?
|
| Sp1 Transcription Factor | 1 | 2000 | 140 | 0.040 |
Why?
|
| Morphogenesis | 2 | 2008 | 740 | 0.040 |
Why?
|
| Alternative Splicing | 2 | 2004 | 1091 | 0.040 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2003 | 886 | 0.040 |
Why?
|
| Cell Extracts | 1 | 2000 | 135 | 0.040 |
Why?
|
| INDEL Mutation | 1 | 2020 | 266 | 0.040 |
Why?
|
| Fibrosis | 1 | 2007 | 2042 | 0.040 |
Why?
|
| Polymorphism, Restriction Fragment Length | 2 | 1991 | 763 | 0.040 |
Why?
|
| STAT4 Transcription Factor | 2 | 2010 | 93 | 0.040 |
Why?
|
| Homozygote | 2 | 2020 | 1788 | 0.040 |
Why?
|
| Meconium Aspiration Syndrome | 1 | 1999 | 30 | 0.040 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2021 | 272 | 0.040 |
Why?
|
| Mycobacterium tuberculosis | 2 | 2008 | 1903 | 0.040 |
Why?
|
| Synapses | 1 | 2009 | 1757 | 0.040 |
Why?
|
| Mutagenesis | 2 | 1993 | 1234 | 0.040 |
Why?
|
| Immunization | 2 | 2002 | 1227 | 0.040 |
Why?
|
| Cell Separation | 5 | 1996 | 1720 | 0.040 |
Why?
|
| Indicators and Reagents | 1 | 2000 | 461 | 0.040 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 1999 | 127 | 0.040 |
Why?
|
| Protein Multimerization | 2 | 2016 | 983 | 0.040 |
Why?
|
| Immunogenetics | 1 | 1979 | 66 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2004 | 995 | 0.040 |
Why?
|
| Genomic Library | 1 | 1999 | 189 | 0.040 |
Why?
|
| Allergens | 2 | 2008 | 1402 | 0.040 |
Why?
|
| Amino Acid Transport Systems, Basic | 1 | 2018 | 33 | 0.040 |
Why?
|
| Receptors, Platelet-Derived Growth Factor | 1 | 1999 | 178 | 0.040 |
Why?
|
| Hypersensitivity, Immediate | 1 | 2001 | 345 | 0.040 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 2005 | 831 | 0.040 |
Why?
|
| Blepharitis | 1 | 1998 | 35 | 0.040 |
Why?
|
| Self Tolerance | 1 | 1999 | 124 | 0.040 |
Why?
|
| Hypersensitivity | 1 | 2008 | 1155 | 0.040 |
Why?
|
| Conserved Sequence | 2 | 2010 | 1167 | 0.040 |
Why?
|
| Isoantibodies | 2 | 1996 | 661 | 0.040 |
Why?
|
| Lymphocytic choriomeningitis virus | 2 | 2004 | 177 | 0.040 |
Why?
|
| Dexamethasone | 3 | 2015 | 1927 | 0.040 |
Why?
|
| Genes, bcl-2 | 1 | 1998 | 119 | 0.040 |
Why?
|
| Heart Transplantation | 2 | 2009 | 3224 | 0.040 |
Why?
|
| Alveolitis, Extrinsic Allergic | 1 | 1998 | 62 | 0.040 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 4 | 1994 | 899 | 0.040 |
Why?
|
| Cell Respiration | 1 | 2018 | 202 | 0.040 |
Why?
|
| Deoxyribonuclease I | 2 | 1989 | 224 | 0.040 |
Why?
|
| Insurance Coverage | 1 | 2009 | 1939 | 0.040 |
Why?
|
| Binding, Competitive | 3 | 1991 | 1142 | 0.040 |
Why?
|
| Central Nervous System | 2 | 1996 | 1334 | 0.040 |
Why?
|
| Actins | 1 | 2005 | 2049 | 0.040 |
Why?
|
| Viral Proteins | 1 | 2005 | 1802 | 0.040 |
Why?
|
| Sensitivity and Specificity | 2 | 2007 | 14660 | 0.040 |
Why?
|
| Receptors, Antigen, B-Cell | 2 | 1993 | 545 | 0.040 |
Why?
|
| Epigenesis, Genetic | 2 | 2021 | 3758 | 0.040 |
Why?
|
| Herpes Simplex | 1 | 2001 | 478 | 0.040 |
Why?
|
| Alleles | 4 | 2004 | 6898 | 0.040 |
Why?
|
| Luminescent Proteins | 1 | 2000 | 835 | 0.040 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 3 | 1990 | 1744 | 0.040 |
Why?
|
| Histones | 2 | 2010 | 2583 | 0.030 |
Why?
|
| Cataract | 1 | 2003 | 827 | 0.030 |
Why?
|
| Cyclooxygenase 2 | 1 | 2019 | 599 | 0.030 |
Why?
|
| Ascites | 1 | 2018 | 338 | 0.030 |
Why?
|
| Inverted Repeat Sequences | 1 | 2016 | 61 | 0.030 |
Why?
|
| Antibody Specificity | 2 | 1996 | 1060 | 0.030 |
Why?
|
| Insulin Receptor Substrate Proteins | 2 | 2011 | 557 | 0.030 |
Why?
|
| Diacylglycerol O-Acyltransferase | 1 | 2016 | 20 | 0.030 |
Why?
|
| Hepatectomy | 1 | 2000 | 559 | 0.030 |
Why?
|
| Species Specificity | 3 | 1987 | 2418 | 0.030 |
Why?
|
| RNA-Binding Proteins | 1 | 2005 | 1894 | 0.030 |
Why?
|
| Goals | 1 | 2021 | 708 | 0.030 |
Why?
|
| Ovariectomy | 1 | 2018 | 611 | 0.030 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2006 | 2895 | 0.030 |
Why?
|
| Lupus Nephritis | 2 | 1990 | 318 | 0.030 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2004 | 1869 | 0.030 |
Why?
|
| Human T-lymphotropic virus 1 | 1 | 1996 | 142 | 0.030 |
Why?
|
| Brain | 4 | 2008 | 26951 | 0.030 |
Why?
|
| Fos-Related Antigen-2 | 1 | 1995 | 14 | 0.030 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2014 | 9276 | 0.030 |
Why?
|
| Cell Transformation, Viral | 3 | 1990 | 526 | 0.030 |
Why?
|
| Genetic Complementation Test | 1 | 1996 | 555 | 0.030 |
Why?
|
| Consensus Sequence | 1 | 1996 | 365 | 0.030 |
Why?
|
| Protein Structure, Quaternary | 1 | 2016 | 428 | 0.030 |
Why?
|
| Glycosylation | 1 | 2018 | 1096 | 0.030 |
Why?
|
| Splenomegaly | 1 | 1996 | 189 | 0.030 |
Why?
|
| TATA Box | 1 | 1995 | 127 | 0.030 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2000 | 1055 | 0.030 |
Why?
|
| Chickens | 2 | 1989 | 860 | 0.030 |
Why?
|
| Fracture Healing | 1 | 2018 | 438 | 0.030 |
Why?
|
| MAP Kinase Kinase 6 | 1 | 2014 | 20 | 0.030 |
Why?
|
| MAP Kinase Kinase 3 | 1 | 2014 | 20 | 0.030 |
Why?
|
| Amelogenin | 1 | 2014 | 14 | 0.030 |
Why?
|
| Herpesvirus 1, Human | 1 | 2001 | 753 | 0.030 |
Why?
|
| Integrin beta4 | 1 | 2014 | 31 | 0.030 |
Why?
|
| Proteolipids | 1 | 1995 | 113 | 0.030 |
Why?
|
| Immunoglobulin Switch Region | 2 | 1991 | 45 | 0.030 |
Why?
|
| Genes, Recessive | 2 | 1996 | 626 | 0.030 |
Why?
|
| Osteoporosis, Postmenopausal | 1 | 2018 | 393 | 0.030 |
Why?
|
| Matrix Metalloproteinase 3 | 2 | 1994 | 138 | 0.030 |
Why?
|
| Tuberculosis | 1 | 2008 | 2001 | 0.030 |
Why?
|
| Obesity | 2 | 2009 | 12922 | 0.030 |
Why?
|
| Synovitis, Pigmented Villonodular | 1 | 1994 | 32 | 0.030 |
Why?
|
| Liver Diseases | 1 | 2003 | 1302 | 0.030 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2005 | 1403 | 0.030 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 1996 | 465 | 0.030 |
Why?
|
| Retroviridae | 2 | 2008 | 850 | 0.030 |
Why?
|
| Antibodies, Protozoan | 1 | 1996 | 251 | 0.030 |
Why?
|
| Leukodystrophy, Globoid Cell | 1 | 1994 | 38 | 0.030 |
Why?
|
| Receptors, CXCR3 | 2 | 2006 | 238 | 0.030 |
Why?
|
| Ionomycin | 1 | 1994 | 109 | 0.030 |
Why?
|
| CD40 Ligand | 1 | 1996 | 521 | 0.030 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2016 | 453 | 0.030 |
Why?
|
| Drosophila | 1 | 2002 | 1492 | 0.030 |
Why?
|
| Long-Term Potentiation | 1 | 2016 | 293 | 0.030 |
Why?
|
| Acute Disease | 2 | 2009 | 7269 | 0.030 |
Why?
|
| Cycloheximide | 3 | 1991 | 343 | 0.030 |
Why?
|
| Plant Lectins | 1 | 1994 | 103 | 0.030 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1996 | 783 | 0.030 |
Why?
|
| Blotting, Southern | 2 | 1993 | 777 | 0.030 |
Why?
|
| p21-Activated Kinases | 1 | 2014 | 128 | 0.030 |
Why?
|
| Osteopontin | 2 | 2006 | 302 | 0.030 |
Why?
|
| Escherichia coli | 2 | 2016 | 4219 | 0.030 |
Why?
|
| Electrophoresis | 1 | 1993 | 234 | 0.030 |
Why?
|
| 5'-Nucleotidase | 1 | 2015 | 161 | 0.030 |
Why?
|
| Staphylococcal Food Poisoning | 1 | 1993 | 3 | 0.030 |
Why?
|
| Molecular Sequence Annotation | 1 | 2016 | 524 | 0.030 |
Why?
|
| Protein Structure, Secondary | 1 | 2016 | 1229 | 0.030 |
Why?
|
| Receptor-CD3 Complex, Antigen, T-Cell | 1 | 1993 | 67 | 0.030 |
Why?
|
| Chromosome Deletion | 2 | 1990 | 1387 | 0.030 |
Why?
|
| Blood | 1 | 1996 | 586 | 0.030 |
Why?
|
| Tissue Inhibitor of Metalloproteinases | 1 | 1993 | 97 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2021 | 2005 | 0.030 |
Why?
|
| Testis | 1 | 1996 | 794 | 0.030 |
Why?
|
| Prognosis | 1 | 2014 | 29658 | 0.030 |
Why?
|
| Phosphoserine | 1 | 2013 | 203 | 0.030 |
Why?
|
| Vaccination | 2 | 1996 | 3361 | 0.030 |
Why?
|
| Langerhans Cells | 1 | 1993 | 171 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 2003 | 3726 | 0.030 |
Why?
|
| Polymerization | 1 | 2013 | 157 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 1997 | 1493 | 0.030 |
Why?
|
| Transplantation Immunology | 1 | 1995 | 532 | 0.030 |
Why?
|
| Vibrissae | 1 | 1993 | 116 | 0.030 |
Why?
|
| Heterozygote | 3 | 2011 | 2798 | 0.030 |
Why?
|
| Xenopus laevis | 1 | 2016 | 965 | 0.030 |
Why?
|
| Matrix Attachment Region Binding Proteins | 1 | 2012 | 47 | 0.030 |
Why?
|
| Activating Transcription Factors | 1 | 1992 | 30 | 0.030 |
Why?
|
| Receptors, Interleukin-13 | 1 | 2012 | 13 | 0.030 |
Why?
|
| Cytochrome P-450 CYP2E1 | 1 | 2012 | 35 | 0.030 |
Why?
|
| Cytoprotection | 1 | 2013 | 200 | 0.030 |
Why?
|
| Swine | 2 | 1997 | 5899 | 0.030 |
Why?
|
| Lymphoid Enhancer-Binding Factor 1 | 1 | 2012 | 84 | 0.030 |
Why?
|
| Caregivers | 1 | 2004 | 2224 | 0.030 |
Why?
|
| Axotomy | 1 | 2012 | 71 | 0.030 |
Why?
|
| Protein Transport | 2 | 2010 | 1964 | 0.030 |
Why?
|
| 8-Bromo Cyclic Adenosine Monophosphate | 1 | 1991 | 73 | 0.030 |
Why?
|
| Cell Membrane | 5 | 2008 | 3682 | 0.030 |
Why?
|
| Immunoglobulin epsilon-Chains | 1 | 1991 | 16 | 0.030 |
Why?
|
| Cytochrome P-450 CYP1A2 | 1 | 2012 | 69 | 0.030 |
Why?
|
| Fungal Proteins | 1 | 1996 | 911 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2015 | 747 | 0.020 |
Why?
|
| Crystallography, X-Ray | 1 | 2016 | 1982 | 0.020 |
Why?
|
| Tooth | 1 | 1993 | 208 | 0.020 |
Why?
|
| Antisense Elements (Genetics) | 1 | 1991 | 37 | 0.020 |
Why?
|
| Receptors, Lipoprotein | 1 | 2011 | 88 | 0.020 |
Why?
|
| GATA1 Transcription Factor | 1 | 2012 | 296 | 0.020 |
Why?
|
| Immunosorbent Techniques | 1 | 1991 | 176 | 0.020 |
Why?
|
| Motivation | 1 | 2021 | 1993 | 0.020 |
Why?
|
| Abelson murine leukemia virus | 2 | 1991 | 41 | 0.020 |
Why?
|
| Stromal Cells | 1 | 1997 | 1326 | 0.020 |
Why?
|
| Metalloproteins | 1 | 1991 | 101 | 0.020 |
Why?
|
| Epistasis, Genetic | 1 | 2013 | 350 | 0.020 |
Why?
|
| Mice, Inbred NOD | 2 | 2009 | 1837 | 0.020 |
Why?
|
| Apolipoproteins A | 1 | 2011 | 95 | 0.020 |
Why?
|
| Integrin alpha6 | 1 | 2010 | 30 | 0.020 |
Why?
|
| Ikaros Transcription Factor | 1 | 2012 | 231 | 0.020 |
Why?
|
| Neovascularization, Physiologic | 1 | 2018 | 1336 | 0.020 |
Why?
|
| SOXD Transcription Factors | 1 | 2010 | 44 | 0.020 |
Why?
|
| Lipoprotein Lipase | 1 | 2011 | 134 | 0.020 |
Why?
|
| Amino Acid Motifs | 1 | 2013 | 929 | 0.020 |
Why?
|
| Eukaryotic Initiation Factor-2 | 1 | 2011 | 180 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 2021 | 2754 | 0.020 |
Why?
|
| Receptor Activator of Nuclear Factor-kappa B | 1 | 2010 | 77 | 0.020 |
Why?
|
| SOX9 Transcription Factor | 1 | 2011 | 145 | 0.020 |
Why?
|
| Models, Genetic | 3 | 2008 | 3442 | 0.020 |
Why?
|
| Peptides | 4 | 1996 | 4354 | 0.020 |
Why?
|
| Core Binding Factor Alpha 3 Subunit | 1 | 2010 | 57 | 0.020 |
Why?
|
| Trichinellosis | 1 | 2010 | 27 | 0.020 |
Why?
|
| Trichinella spiralis | 1 | 2010 | 22 | 0.020 |
Why?
|
| CD4 Lymphocyte Count | 1 | 1996 | 2569 | 0.020 |
Why?
|
| Fermentation | 1 | 2010 | 146 | 0.020 |
Why?
|
| Mutagenesis, Insertional | 1 | 1993 | 652 | 0.020 |
Why?
|
| Adult | 7 | 2011 | 219994 | 0.020 |
Why?
|
| Single-Cell Analysis | 1 | 2021 | 2380 | 0.020 |
Why?
|
| Alkaline Phosphatase | 1 | 1993 | 865 | 0.020 |
Why?
|
| Genes, Immunoglobulin | 1 | 1991 | 285 | 0.020 |
Why?
|
| Secretory Vesicles | 1 | 2010 | 128 | 0.020 |
Why?
|
| Evoked Potentials | 1 | 2016 | 1036 | 0.020 |
Why?
|
| Transcription Initiation Site | 1 | 2010 | 186 | 0.020 |
Why?
|
| Lung Diseases, Interstitial | 1 | 1998 | 911 | 0.020 |
Why?
|
| Medroxyprogesterone Acetate | 1 | 2010 | 155 | 0.020 |
Why?
|
| Bucladesine | 2 | 1989 | 118 | 0.020 |
Why?
|
| Immunoglobulin Joining Region | 1 | 1989 | 37 | 0.020 |
Why?
|
| Bacterial Proteins | 1 | 2003 | 3826 | 0.020 |
Why?
|
| Enzyme Induction | 1 | 1990 | 452 | 0.020 |
Why?
|
| Gene Rearrangement, T-Lymphocyte | 1 | 1989 | 111 | 0.020 |
Why?
|
| Gamma Rays | 1 | 2010 | 317 | 0.020 |
Why?
|
| Islets of Langerhans | 2 | 2009 | 1345 | 0.020 |
Why?
|
| Apolipoproteins | 1 | 2011 | 320 | 0.020 |
Why?
|
| Tumor Suppressor Proteins | 1 | 1999 | 2802 | 0.020 |
Why?
|
| DNA Restriction Enzymes | 2 | 1986 | 553 | 0.020 |
Why?
|
| Osteopetrosis | 1 | 2008 | 43 | 0.020 |
Why?
|
| High-Throughput Screening Assays | 1 | 2015 | 944 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 1993 | 1600 | 0.020 |
Why?
|
| Mammary Glands, Animal | 1 | 1990 | 271 | 0.020 |
Why?
|
| Phosphoproteins | 2 | 2010 | 2440 | 0.020 |
Why?
|
| Chloride-Bicarbonate Antiporters | 1 | 2008 | 103 | 0.020 |
Why?
|
| Peritoneum | 1 | 2010 | 224 | 0.020 |
Why?
|
| Lyme Disease | 1 | 1995 | 630 | 0.020 |
Why?
|
| Heart | 2 | 2006 | 4393 | 0.020 |
Why?
|
| Interleukin-16 | 1 | 2008 | 34 | 0.020 |
Why?
|
| Leucine | 1 | 1990 | 547 | 0.020 |
Why?
|
| Receptors, Interleukin-7 | 1 | 2008 | 40 | 0.020 |
Why?
|
| Interleukin-2 Receptor beta Subunit | 1 | 2008 | 25 | 0.020 |
Why?
|
| Tubulin | 1 | 2012 | 692 | 0.020 |
Why?
|
| Paneth Cells | 1 | 2008 | 98 | 0.020 |
Why?
|
| Integrases | 1 | 2010 | 516 | 0.020 |
Why?
|
| Vagina | 1 | 1993 | 837 | 0.020 |
Why?
|
| Immunoglobulin Variable Region | 1 | 1989 | 419 | 0.020 |
Why?
|
| Liver Neoplasms | 1 | 2004 | 4319 | 0.020 |
Why?
|
| Information Systems | 1 | 1990 | 398 | 0.020 |
Why?
|
| Antigenic Variation | 1 | 1988 | 118 | 0.020 |
Why?
|
| Gene Rearrangement, B-Lymphocyte | 1 | 1988 | 112 | 0.020 |
Why?
|
| Oncogenes | 1 | 1993 | 1220 | 0.020 |
Why?
|
| Isoelectric Point | 1 | 1987 | 76 | 0.020 |
Why?
|
| Germ-Line Mutation | 1 | 1996 | 1841 | 0.020 |
Why?
|
| Adipose Tissue | 2 | 2004 | 3301 | 0.020 |
Why?
|
| Interleukin-1 | 3 | 1991 | 1249 | 0.020 |
Why?
|
| Mycobacterium bovis | 1 | 2008 | 147 | 0.020 |
Why?
|
| Serine Endopeptidases | 1 | 2012 | 1021 | 0.020 |
Why?
|
| Mucoproteins | 1 | 2007 | 49 | 0.020 |
Why?
|
| Epithelial Cells | 3 | 2010 | 3663 | 0.020 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 1993 | 1112 | 0.020 |
Why?
|
| Kidney Neoplasms | 1 | 2004 | 4312 | 0.020 |
Why?
|
| Calcimycin | 1 | 1986 | 213 | 0.020 |
Why?
|
| Cattle | 2 | 1983 | 3847 | 0.020 |
Why?
|
| Liver Diseases, Parasitic | 1 | 2006 | 9 | 0.020 |
Why?
|
| Dependovirus | 1 | 2012 | 709 | 0.020 |
Why?
|
| Apolipoproteins E | 1 | 2012 | 1436 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2009 | 858 | 0.020 |
Why?
|
| Doxycycline | 1 | 2008 | 341 | 0.020 |
Why?
|
| Growth Inhibitors | 1 | 2008 | 378 | 0.020 |
Why?
|
| Cytochrome c Group | 2 | 1983 | 122 | 0.020 |
Why?
|
| DNA Methylation | 1 | 2020 | 4373 | 0.020 |
Why?
|
| Fatty Liver | 1 | 2012 | 778 | 0.020 |
Why?
|
| Receptors, Glucocorticoid | 1 | 1988 | 296 | 0.020 |
Why?
|
| Receptors, Interleukin-2 | 2 | 2004 | 562 | 0.020 |
Why?
|
| Giant Cells, Langhans | 1 | 2005 | 2 | 0.020 |
Why?
|
| Collagen | 1 | 1994 | 2636 | 0.020 |
Why?
|
| Muscle, Skeletal | 2 | 2004 | 4925 | 0.020 |
Why?
|
| Immunoglobulin gamma-Chains | 1 | 1985 | 33 | 0.020 |
Why?
|
| Cross-Priming | 1 | 2006 | 75 | 0.020 |
Why?
|
| Radiation Chimera | 2 | 1985 | 216 | 0.020 |
Why?
|
| Amino Acids | 1 | 2012 | 1714 | 0.020 |
Why?
|
| Endothelium, Vascular | 1 | 1998 | 4433 | 0.020 |
Why?
|
| Cytotoxicity Tests, Immunologic | 2 | 1994 | 321 | 0.020 |
Why?
|
| Cytosol | 1 | 1989 | 887 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2008 | 15697 | 0.020 |
Why?
|
| Antigens, CD34 | 1 | 2008 | 653 | 0.020 |
Why?
|
| Corpus Striatum | 1 | 2012 | 1233 | 0.020 |
Why?
|
| Microglia | 1 | 1994 | 1351 | 0.020 |
Why?
|
| Goblet Cells | 1 | 2008 | 299 | 0.020 |
Why?
|
| Neoplasms, Experimental | 2 | 1982 | 1229 | 0.020 |
Why?
|
| Receptors, Prostaglandin | 1 | 1985 | 53 | 0.020 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2010 | 633 | 0.020 |
Why?
|
| Child, Preschool | 3 | 2020 | 42063 | 0.020 |
Why?
|
| Receptors, Prostaglandin E | 1 | 1985 | 56 | 0.020 |
Why?
|
| Karyotyping | 1 | 1987 | 1171 | 0.020 |
Why?
|
| Oocytes | 1 | 1990 | 1165 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2009 | 2471 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 8 | 1 | 2004 | 74 | 0.020 |
Why?
|
| Bacterial Toxins | 1 | 1990 | 931 | 0.010 |
Why?
|
| Syndrome | 1 | 1991 | 3280 | 0.010 |
Why?
|
| Receptors, Interleukin-12 | 1 | 2004 | 26 | 0.010 |
Why?
|
| Receptors, Interleukin-18 | 1 | 2004 | 24 | 0.010 |
Why?
|
| Molecular Weight | 1 | 1987 | 2186 | 0.010 |
Why?
|
| Interleukin-18 Receptor alpha Subunit | 1 | 2004 | 18 | 0.010 |
Why?
|
| Protein Kinases | 1 | 1991 | 1612 | 0.010 |
Why?
|
| Immunoglobulin Light Chains | 1 | 2005 | 286 | 0.010 |
Why?
|
| Antibody-Producing Cells | 1 | 2004 | 140 | 0.010 |
Why?
|
| Myelin-Associated Glycoprotein | 1 | 2004 | 107 | 0.010 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2007 | 691 | 0.010 |
Why?
|
| Protein Kinase C | 1 | 1989 | 1199 | 0.010 |
Why?
|
| Survival Rate | 1 | 2018 | 12808 | 0.010 |
Why?
|
| Middle Aged | 6 | 2011 | 220352 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2008 | 556 | 0.010 |
Why?
|
| Chronic Disease | 1 | 1999 | 9287 | 0.010 |
Why?
|
| Eosinophilia | 1 | 2008 | 559 | 0.010 |
Why?
|
| Histidine | 1 | 2004 | 311 | 0.010 |
Why?
|
| Receptors, Steroid | 1 | 1984 | 154 | 0.010 |
Why?
|
| Rectal Prolapse | 1 | 2004 | 33 | 0.010 |
Why?
|
| Gastric Mucosa | 1 | 2007 | 599 | 0.010 |
Why?
|
| Immunoglobulin Idiotypes | 1 | 1983 | 200 | 0.010 |
Why?
|
| Mice, Obese | 1 | 2004 | 420 | 0.010 |
Why?
|
| Myelin Proteins | 1 | 2004 | 208 | 0.010 |
Why?
|
| Respiratory Mucosa | 1 | 2007 | 441 | 0.010 |
Why?
|
| Biopsy | 1 | 2015 | 6771 | 0.010 |
Why?
|
| beta 2-Microglobulin | 2 | 1994 | 328 | 0.010 |
Why?
|
| Biological Transport | 1 | 1988 | 2086 | 0.010 |
Why?
|
| Culture Media | 1 | 1985 | 900 | 0.010 |
Why?
|
| Bone Marrow | 1 | 1993 | 2912 | 0.010 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2008 | 498 | 0.010 |
Why?
|
| Genes, RAG-1 | 1 | 2002 | 67 | 0.010 |
Why?
|
| Simian virus 40 | 1 | 1983 | 291 | 0.010 |
Why?
|
| Glaucoma | 1 | 2012 | 1182 | 0.010 |
Why?
|
| DNA, Recombinant | 1 | 1982 | 455 | 0.010 |
Why?
|
| Centrifugation, Density Gradient | 1 | 1981 | 299 | 0.010 |
Why?
|
| Genes, ras | 1 | 2004 | 655 | 0.010 |
Why?
|
| Cholesterol, LDL | 1 | 2011 | 2420 | 0.010 |
Why?
|
| Administration, Inhalation | 1 | 2004 | 1156 | 0.010 |
Why?
|
| Genetic Code | 1 | 1981 | 138 | 0.010 |
Why?
|
| Hybridization, Genetic | 2 | 1993 | 103 | 0.010 |
Why?
|
| Viral Envelope Proteins | 1 | 2005 | 638 | 0.010 |
Why?
|
| Sheep | 1 | 1983 | 1441 | 0.010 |
Why?
|
| Serum Albumin, Bovine | 1 | 1981 | 323 | 0.010 |
Why?
|
| ets-Domain Protein Elk-1 | 1 | 2000 | 39 | 0.010 |
Why?
|
| Thymoma | 1 | 1982 | 187 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2012 | 8158 | 0.010 |
Why?
|
| Receptor, Insulin | 1 | 2004 | 836 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2011 | 4713 | 0.010 |
Why?
|
| DNA Damage | 1 | 2010 | 2442 | 0.010 |
Why?
|
| Computational Biology | 1 | 2012 | 3505 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2004 | 12293 | 0.010 |
Why?
|
| Drosophila melanogaster | 1 | 2009 | 1710 | 0.010 |
Why?
|
| DNA Mutational Analysis | 2 | 2003 | 4107 | 0.010 |
Why?
|
| Thymus Neoplasms | 1 | 1982 | 274 | 0.010 |
Why?
|
| Acetylation | 1 | 2002 | 1062 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-ets | 1 | 2000 | 311 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2011 | 9716 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 2 | 1994 | 1705 | 0.010 |
Why?
|
| Immunotherapy | 1 | 1995 | 4642 | 0.010 |
Why?
|
| Absorption | 1 | 1979 | 243 | 0.010 |
Why?
|
| Expressed Sequence Tags | 1 | 1999 | 250 | 0.010 |
Why?
|
| Infant | 1 | 2020 | 36060 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2009 | 6544 | 0.010 |
Why?
|
| Immune Sera | 1 | 1979 | 613 | 0.010 |
Why?
|
| Macrophages, Peritoneal | 1 | 1999 | 237 | 0.010 |
Why?
|
| Fetal Blood | 1 | 1985 | 1343 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2015 | 8950 | 0.010 |
Why?
|
| Kidney Transplantation | 1 | 1993 | 4215 | 0.010 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 1999 | 227 | 0.010 |
Why?
|
| Genomics | 1 | 2013 | 5794 | 0.010 |
Why?
|
| Antigens, Neoplasm | 1 | 1985 | 1998 | 0.010 |
Why?
|
| Leukemia Virus, Murine | 1 | 1977 | 94 | 0.010 |
Why?
|
| Kinetics | 1 | 1984 | 6377 | 0.010 |
Why?
|
| Dermatitis, Atopic | 1 | 2004 | 716 | 0.010 |
Why?
|
| Cell Cycle | 1 | 1985 | 2934 | 0.010 |
Why?
|
| Leukemia, Experimental | 1 | 1977 | 225 | 0.010 |
Why?
|
| RNA, Neoplasm | 1 | 1999 | 749 | 0.010 |
Why?
|
| Intercellular Adhesion Molecule-1 | 2 | 1990 | 1126 | 0.010 |
Why?
|
| Subtraction Technique | 1 | 1999 | 510 | 0.010 |
Why?
|
| Solubility | 1 | 1998 | 1088 | 0.010 |
Why?
|
| Immunoglobulin Fc Fragments | 1 | 1998 | 280 | 0.010 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 1 | 1998 | 346 | 0.010 |
Why?
|
| Complement System Proteins | 1 | 1979 | 782 | 0.010 |
Why?
|
| Rabbits | 1 | 1982 | 4773 | 0.010 |
Why?
|
| Borrelia burgdorferi Group | 1 | 1995 | 97 | 0.010 |
Why?
|
| Galactosylceramidase | 1 | 1994 | 23 | 0.010 |
Why?
|
| Mice, Neurologic Mutants | 1 | 1994 | 107 | 0.010 |
Why?
|
| Antibody-Dependent Cell Cytotoxicity | 1 | 1996 | 303 | 0.010 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2004 | 2828 | 0.010 |
Why?
|
| Aged | 4 | 2011 | 169152 | 0.010 |
Why?
|
| Chemotactic Factors | 1 | 1995 | 196 | 0.010 |
Why?
|
| Cosmids | 1 | 1993 | 105 | 0.010 |
Why?
|
| Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 1 | 1993 | 93 | 0.010 |
Why?
|
| Immunization, Passive | 1 | 1996 | 616 | 0.010 |
Why?
|
| Microscopy, Immunoelectron | 1 | 1993 | 317 | 0.010 |
Why?
|
| Pancreatitis | 1 | 2001 | 1100 | 0.010 |
Why?
|
| Genotype | 2 | 2004 | 12960 | 0.010 |
Why?
|
| Thymectomy | 1 | 1994 | 194 | 0.010 |
Why?
|
| Conalbumin | 1 | 1992 | 5 | 0.010 |
Why?
|
| Vaccines, Synthetic | 1 | 1995 | 617 | 0.010 |
Why?
|
| Lectins | 1 | 1994 | 484 | 0.010 |
Why?
|
| Immunoglobulin Constant Regions | 1 | 1991 | 58 | 0.010 |
Why?
|
| Haplotypes | 1 | 1998 | 2764 | 0.010 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 1 | 1990 | 168 | 0.010 |
Why?
|
| Lectins, C-Type | 1 | 1993 | 587 | 0.010 |
Why?
|
| Glomerular Mesangium | 1 | 1990 | 98 | 0.010 |
Why?
|
| Placenta | 1 | 1999 | 1702 | 0.010 |
Why?
|
| Fixatives | 1 | 1989 | 91 | 0.010 |
Why?
|
| Microvilli | 1 | 1990 | 233 | 0.010 |
Why?
|
| DNA Probes | 1 | 1990 | 551 | 0.010 |
Why?
|
| Kidney Cortex | 1 | 1989 | 169 | 0.000 |
Why?
|
| Cohort Studies | 1 | 2011 | 41335 | 0.000 |
Why?
|
| Antibodies, Bacterial | 1 | 1995 | 1468 | 0.000 |
Why?
|
| Rectum | 1 | 1993 | 895 | 0.000 |
Why?
|
| Estrenes | 1 | 1988 | 21 | 0.000 |
Why?
|
| Clinical Trials as Topic | 1 | 2004 | 8056 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 2015 | 65017 | 0.000 |
Why?
|
| Oligonucleotides | 1 | 1991 | 588 | 0.000 |
Why?
|
| Mifepristone | 1 | 1988 | 150 | 0.000 |
Why?
|
| Nephrectomy | 1 | 1993 | 1016 | 0.000 |
Why?
|
| Child | 2 | 2005 | 79806 | 0.000 |
Why?
|
| Ethyl Methanesulfonate | 1 | 1986 | 29 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 1991 | 58995 | 0.000 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2005 | 15789 | 0.000 |
Why?
|
| Trinitrobenzenes | 1 | 1985 | 46 | 0.000 |
Why?
|
| Concanavalin A | 1 | 1985 | 190 | 0.000 |
Why?
|
| Chemistry | 1 | 1985 | 348 | 0.000 |
Why?
|
| Ligands | 1 | 1992 | 3276 | 0.000 |
Why?
|
| Chemical Phenomena | 1 | 1985 | 508 | 0.000 |
Why?
|
| Columbidae | 1 | 1983 | 40 | 0.000 |
Why?
|
| Transformation, Genetic | 1 | 1984 | 192 | 0.000 |
Why?
|
| Diabetes Mellitus | 1 | 2001 | 5889 | 0.000 |
Why?
|
| Myocardium | 1 | 1995 | 4700 | 0.000 |
Why?
|
| Guinea Pigs | 1 | 1983 | 1316 | 0.000 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1985 | 1544 | 0.000 |
Why?
|
| Recombination, Genetic | 1 | 1986 | 1526 | 0.000 |
Why?
|
| Binding Sites, Antibody | 1 | 1981 | 337 | 0.000 |
Why?
|
| Genetic Linkage | 1 | 1986 | 2381 | 0.000 |
Why?
|
| Parainfluenza Virus 1, Human | 1 | 1978 | 25 | 0.000 |
Why?
|
| Infant, Newborn | 1 | 1999 | 26181 | 0.000 |
Why?
|
| BCG Vaccine | 1 | 1981 | 371 | 0.000 |
Why?
|
| Adolescent | 1 | 2005 | 87810 | 0.000 |
Why?
|
| Cross Reactions | 1 | 1978 | 818 | 0.000 |
Why?
|
| Mitosis | 1 | 1981 | 1191 | 0.000 |
Why?
|
| Monocytes | 1 | 1984 | 2575 | 0.000 |
Why?
|
| Erythrocytes | 1 | 1981 | 2415 | 0.000 |
Why?
|